Company
Rimsys
Rimsys connects AI-native market planning with AI-embedded regulatory execution, giving medtech manufacturers a single system instead of a fragmented, market-by-market process.
Also known as Rimsys Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- medtech manufacturers
- Legal name
- Rimsys Inc.
Record updated 28 September 2026
About
Rimsys is the heart of regulatory operations, connecting AI-native market planning with AI-embedded regulatory execution, giving medtech manufacturers one living system from market-entry decision to execution.
Funding snapshot
- Total raised
- $24.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.3M2024-03-28
Funding rounds
- Round, 2024
- $5.3M2024-03-28, SEC form D sold, 24 investors
- Round, 2021
- $15.9M2021-11-19, SEC form D sold, 13 investors
- Round, 2020
- $3M2020-04-07, SEC form D sold, 7 investors
Products
- Web
- Market Access
- Web
- Rimsys RIM